DK0458823T3 - Fremgangsmåde til fremstilling af enantiomerisk rene polysubstituerede 1,4-dihydropridiner - Google Patents

Fremgangsmåde til fremstilling af enantiomerisk rene polysubstituerede 1,4-dihydropridiner

Info

Publication number
DK0458823T3
DK0458823T3 DK90903015.7T DK90903015T DK0458823T3 DK 0458823 T3 DK0458823 T3 DK 0458823T3 DK 90903015 T DK90903015 T DK 90903015T DK 0458823 T3 DK0458823 T3 DK 0458823T3
Authority
DK
Denmark
Prior art keywords
dihydropyridines
enantiomerically pure
dihydropridines
polysubstituted
preparation
Prior art date
Application number
DK90903015.7T
Other languages
Danish (da)
English (en)
Inventor
Carmelo A Gandolfi
Marco Frigerio
Carlo Riva
Andrea Zaliani
Giorgio Long
Domenico Roberto Di
Original Assignee
Boehringer Mannheim Italia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Italia filed Critical Boehringer Mannheim Italia
Application granted granted Critical
Publication of DK0458823T3 publication Critical patent/DK0458823T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK90903015.7T 1989-02-17 1990-02-15 Fremgangsmåde til fremstilling af enantiomerisk rene polysubstituerede 1,4-dihydropridiner DK0458823T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8919477A IT1230752B (it) 1989-02-17 1989-02-17 Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura.

Publications (1)

Publication Number Publication Date
DK0458823T3 true DK0458823T3 (da) 1994-02-21

Family

ID=11158352

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90903015.7T DK0458823T3 (da) 1989-02-17 1990-02-15 Fremgangsmåde til fremstilling af enantiomerisk rene polysubstituerede 1,4-dihydropridiner

Country Status (17)

Country Link
US (1) US5245039A (ko)
EP (2) EP0383320A1 (ko)
JP (1) JPH04505610A (ko)
KR (1) KR0155557B1 (ko)
AT (1) ATE95813T1 (ko)
AU (1) AU630928B2 (ko)
CA (1) CA2047741A1 (ko)
DE (1) DE69003936T2 (ko)
DK (1) DK0458823T3 (ko)
ES (1) ES2060144T3 (ko)
FI (1) FI95371C (ko)
HU (1) HUT62270A (ko)
IE (1) IE66498B1 (ko)
IT (1) IT1230752B (ko)
NO (1) NO177186C (ko)
RU (1) RU2069658C1 (ko)
WO (1) WO1990009376A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571827A (en) * 1990-03-13 1996-11-05 Sepracor Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
US5834496A (en) * 1991-12-02 1998-11-10 Sepracor, Inc. Methods for treating hypertension using optically pure S(-) felodipine
JPH07501551A (ja) * 1991-12-02 1995-02-16 セプラコア,インコーポレーテッド 光学的に純粋なs(−)フェロジピンを用いる,高血圧,狭心症および他の疾患を治療するための方法および組成物
ES2055653B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion del 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isopropil-5-(2-metoxi)etil.
ES2055652B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(2,3-diclorofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil.
ES2055654B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil.
ES2055655B1 (es) * 1992-09-22 1995-03-01 Elmuquimica Farm Sl Procedimiento de obtencion de 2,6-dimetil-4-(2-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isobutil-5-metil.
GB9405833D0 (en) * 1994-03-24 1994-05-11 Pfizer Ltd Separation of the enantiomers of amlodipine
FR2719585B1 (fr) * 1994-05-05 1996-08-02 Lafon Labor Procédé d'obtention de 1,4-dihydropyridines optiquement pures.
US5554621A (en) * 1995-06-07 1996-09-10 Bristol-Myers Squibb Company Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives
ITMI20012434A1 (it) 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
HU199796B (en) * 1985-08-06 1990-03-28 Boehringer Biochemia Srl Process for producing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions comprising such compounds
EP0225175A3 (en) * 1985-11-28 1988-12-28 FISONS plc Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
WO1988007531A1 (en) * 1987-03-27 1988-10-06 Byk Gulden Lomberg Chemische Fabrik Gmbh New optically active compounds
US4994461A (en) * 1987-03-27 1991-02-19 Byk Gulden Lomberg Chemische Fabrik Gmbh 1,4-dihydropyridine enantiomers

Also Published As

Publication number Publication date
AU630928B2 (en) 1992-11-12
DE69003936D1 (de) 1993-11-18
HUT62270A (en) 1993-04-28
NO913188D0 (no) 1991-08-15
EP0383320A1 (en) 1990-08-22
IT1230752B (it) 1991-10-29
NO177186C (no) 1995-08-02
KR0155557B1 (ko) 1998-11-16
FI95371B (fi) 1995-10-13
DE69003936T2 (de) 1994-03-31
IE900584L (en) 1990-08-17
FI913861A0 (fi) 1991-08-15
ATE95813T1 (de) 1993-10-15
IT8919477A0 (it) 1989-02-17
EP0458823B1 (en) 1993-10-13
NO913188L (no) 1991-08-15
CA2047741A1 (en) 1990-08-18
IE66498B1 (en) 1996-01-10
ES2060144T3 (es) 1994-11-16
WO1990009376A1 (en) 1990-08-23
JPH04505610A (ja) 1992-10-01
RU2069658C1 (ru) 1996-11-27
EP0458823A1 (en) 1991-12-04
KR910700234A (ko) 1991-03-14
AU5090490A (en) 1990-09-05
FI95371C (fi) 1996-01-25
US5245039A (en) 1993-09-14
NO177186B (no) 1995-04-24

Similar Documents

Publication Publication Date Title
DK0458823T3 (da) Fremgangsmåde til fremstilling af enantiomerisk rene polysubstituerede 1,4-dihydropridiner
NO20083728L (no) Analogifremgangsmate for fremstilling av et terapeutisk aktivt nukleosid
DK369284A (da) Aprotininhomologe med andre aminosyrer i stilling 15 i stedet for lysin, fremgangsmaade til fremstilling heraf samt deres anvendelse som laegemiddel
DE69311000D1 (de) Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 1-Halogen-2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Derivaten
IT7823679A0 (it) Processo enzimatico-microbiologico per la produzione di amminoacidi otticamente attivi a partire da idantoine e/o carbamil-derivati racemi.
DE68916754D1 (de) Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure.
DK0535939T3 (da) Fremgangsmåde til fremstilling af omega 9-type polyumættet fedtsyre
PT92603A (pt) Processo de producao de factor de crescimento transformante, quimerico,beta
DE69009237D1 (de) Verfahren zur Herstellung von optisch aktiven Estern der 6-t-Butoxy-3,5-dihydroxyhexansäure.
NO177500C (no) Fremgangsmåte til fremstilling av en terapeutisk aktiv hirudinvariant
ES2090075T3 (es) Procedimiento para la preparacion de diastereoisomeros opticamente puros de compuestos de tetrahidrofolato.
DE69007599D1 (de) Verfahren zur Racemisierung optisch aktiver Carbonsäureester.
PT91006A (pt) Processo para a preparacao de um novo sal de estroncio
DK144417C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive alfa-(3,4-dimethoxyphenethylaminomethyl)-2-alkoxybenzylalkoholer eller farmaceutisk anvendelige syreadditionssalte deraf
ATA302677A (de) Verfahren zur herstellung von neuen 1,3-dihydro- heteroarylspiro/isobenzofuran)en und von deren optischen antipoden und pharmazeutisch vertraeglichen saeureadditionssalzen
DE3569725D1 (en) A method for the optical purification of an optically active 2,2-dimethylcyclopropanecarboxylic acid amide
AT375940B (de) Verfahren zur herstellung neuer 10-halogen-14-oxo-15-hydroxy-e-homoeburnane (3 alpha,17 alpha) sowie deren epimeren, optisch aktiven antipoden und physiologisch vertraeglichen saeureadditionssalze
DE69033833D1 (de) Verfahren zur Herstellung von Butantetracarbonsäure
DK149592C (da) Analogifremgangsmaade til fremstilling af racemiske eller optisk aktive1,1-disubstituerede octahydro-indolo(2,3-a)quinoliziner eller farmaceutisk acceptable syreadditionssalte deraf
ATA174887A (de) Verfahren zur herstellung von hydroximinsaeuren von 7-oxabicycloheptansubstituierten prostaglandinether- und -thioetheranalogen und von deren stereoisomeren und pharmazeutisch annehmbaren salzen
DE68920265D1 (de) Verfahren zur Enantiomerentrennung von Cis-3-amino-4-[2-(2-furyl)vinyl]-1-methoxycarbonylmethyl-azetidin-2-on und deren Di-p-Toluoyl-Weinsäuresalze.
ATA18878A (de) Verfahren zur herstellung von (1,1-dithienyl- -(3-propen-(1)-yl-(3))-(1-phenyl-1-hydroxyproyl -(2))-amin und dessen saeureadditionssalzen und optisch aktiven isomeren
ES2089327T3 (es) Procedimiento e intermediarios para la preparacion de un agente antivirico que contiene un grupo ciclobutilo.
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
DE3851942D1 (de) Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure.